Biotech RadarJobs updated

COMPANY

Namida Lab

HQ: Fayetteville, AR source · namidalab.com ↗ · Southeast

Keywords: oncology Breast Cancer Breast Cancer Female Tear Breast Cancer Screening Health Care Utilization Health Knowledge, Attitudes, Practice Health Personnel Attitude Health Care Acceptability Ovarian Cancer Pancreatic Cancer Prostate Cancer Melanoma SARS-CoV 2 Infection Covid19

Location: Fayetteville, AR · source · Oct 15, 2026

Profile checked Oct 10, 2026

5Trials (company is sponsor)

Timeline

  1. Trial start —: A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue source ↗
  2. Trial start —: Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study source ↗
  3. Trial start —: Validation of a Tear-based Screening Assay for Breast Cancer source ↗
  4. Trial start —: Tear Based Sample Collection Breast Cancer Detection source ↗
  5. Trial start —: Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19 source ↗

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT04974567Tear Based Sample Collection Breast Cancer DetectionNot listedUnknown status (ClinicalTrials.gov)Apr 28, 2021Aug 31, 2024 (estimated)
NCT05268224A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast TissueNot listedUnknown status (ClinicalTrials.gov)Oct 1, 20212024-10 (estimated)
NCT04928014Validation of a Tear-based Screening Assay for Breast CancerNot listedUnknown status (ClinicalTrials.gov)Jun 1, 20212023-12 (estimated)
NCT05223218Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot StudyNot listedUnknown status (ClinicalTrials.gov)Aug 25, 20212023-11 (estimated)
NCT04542980Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19Not listedCompletedSep 15, 2020Dec 31, 2020 (actual)
Feedback